Yeben Qian

801 citations
13 papers · 539 indexed · h-index 7
Topics
Autophagy in Disease and Therapy (4 papers)Ferroptosis and cancer prognosis (4 papers)Epigenetics and DNA Methylation (3 papers)
Partner nations
ChinaUnited States

In The Last Decade

Yeben Qian

13 papers receiving 533 citations

Peers

Yeben Qian
Comparison fields: 5 of 67
  • Molecular Biology 250
  • Immunology 192
  • Cancer Research 142
  • Oncology 129
  • Pulmonary and Respiratory Medicine 96
Replace Prashanth Prithviraj with:
Prashanth Prithviraj Australia
Shingo Kagawa Japan
Manik Amin United States
Chuntao Wu China
Alexandra Drakaki United States
Yingfu Liu China
S. Heinrich Germany
Carla Castanaro United States
Colin Graydon Canada
Xianshuo Cheng China
Yeben Qian relative to Prashanth Prithviraj Australia Prashanth Prithviraj's profile →
Citations per field
00.5×1.7×
Prashanth Prithviraj · 1×
Citations per year

Countries citing papers authored by Yeben Qian

Since Specialization
Citations

This map shows the geographic impact of Yeben Qian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yeben Qian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yeben Qian more than expected).

Fields of papers citing papers by Yeben Qian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yeben Qian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yeben Qian. The network helps show where Yeben Qian may publish in the future.

Co-authorship network of co-authors of Yeben Qian

This figure shows the co-authorship network connecting the top 25 collaborators of Yeben Qian. A scholar is included among the top collaborators of Yeben Qian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yeben Qian. Yeben Qian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
#WorkIndexed citations
1 3
2 4
3 6
4 57
5 19
6 37
7 6
8 10
9 207
10 1
11 122
12 64
13
[Clinicopathological significance of aberrant methylation of the fragile histidine triad gene in patients with hepatocellular carcinoma].
3

About Yeben Qian

Yeben Qian is a scholar working on Cancer Research, Epidemiology and Cell Biology, having authored 13 papers that have together received 539 indexed citations. Recurring topics across this work include Autophagy in Disease and Therapy (4 papers), Ferroptosis and cancer prognosis (4 papers) and Epigenetics and DNA Methylation (3 papers). The work is most often cited by research in Cancer Research (142 citations), Immunology (192 citations) and Hepatology (44 citations). Yeben Qian has collaborated with scholars based in China and United States. Frequent co-authors include Haiming Wei, Xiaohu Zheng, Yiqing Shen, Binqing Fu, Rui Sun, Zhigang Tian, Defeng Jiao, Yong Jiang, Yi Zhang and Peng Chen. Their work appears in journals such as Journal of Clinical Oncology, Nature Immunology and ACS Applied Materials & Interfaces.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026